Newly Approved Drug Therapies (378): Teveten, SmithKline Beecham

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Teveten

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: SmithKline Beecham
Approval Status: Approved December 1997
Treatment for: hypertension

General Information

Teveten was approved for the treatment of hypertension, as either a monotherapy or for use in combination with other antihypertensives.

Mechanism of Action

Teveten is an angiotensin II antagonist.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]